ONEMEDNET CORPORATION Accrued Liabilities, Current
ONEMEDNET CORPORATION (ONMD) had Accrued Liabilities, Current of $2.84 million as of 2023-09-30, per its 10-Q/A filed 2023-12-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2023-12-18
- 2023-09-30: Accrued Liabilities, Current $2.84M.
- 2022-12-31: Accrued Liabilities, Current $1.68M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-09-30 | $2.84M 10-Q/A · filed 2023-12-18 |
| 2022-12-31 | $1.68M 10-Q/A · filed 2023-12-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |